1. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Issue 6 (17th November 2008) Authors: Fleischmann, R; Vencovsky, J; van Vollenhoven, R F; Borenstein, D; Box, J; Coteur, G; Goel, N; Brezinschek, H-P; Innes, A; Strand, V Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 6(2009) Page Start: 805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗